A multifunctional human monoclonal neutralizing antibody that targets a unique conserved epitope on influenza HA
Sandhya Bangaru(Government Medical College), James E. Crowe(Vanderbilt University Medical Center), Ian A. Wilson(Raigmore Hospital), Travis Nieusma(Scripps Research Institute), Pavlo Gilchuk(AstraZeneca (Japan)), Pranathi Matta(Vanderbilt University Medical Center), Thomas G. Voss(Vanderbilt University Medical Center), Stephen J. Kent(The University of Melbourne), Hillary A. Vanderven(Australian Institute of Tropical Health and Medicine), Ryan P. Irving(Vanderbilt University Medical Center), Robin Bombardi(Vanderbilt University Medical Center), H. Zhang(Scripps Research Institute), Xueyong Zhu(Scripps Research Institute), Andrew B. Ward(Scripps Research Institute), Jüergen A. Richt(Kansas State University), Iuliia M. Gilchuk(Vanderbilt University Medical Center), Shanshan Lang(Scripps Research Institute), Randy A. Albrecht(Icahn School of Medicine at Mount Sinai)
Cited by 109
Related Papers
Immunogenicity and structures of a rationally designed prefusion MERS-CoV spike antigen
|Proceedings of the National Academy of Sciences|2017|1.2k
Complete Mapping of Mutations to the SARS-CoV-2 Spike Receptor-Binding Domain that Escape Antibody Recognition
|Cell Host & Microbe|2020|1.2k
Resistance of SARS-CoV-2 variants to neutralization by monoclonal and serum-derived polyclonal antibodies
|Nature Medicine|2021|1k
Structure of the SARS-CoV nsp12 polymerase bound to nsp7 and nsp8 co-factors
|Nature Communications|2019|948